🔎 Trials Near Me

Dachaigh › Colitis Ulcerative › New York

Sgrùdaidhean clionaigeach Colitis Ulcerative ann an New York

Tha 30 sgrùdaidhean airson Colitis Ulcerative a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

  • New York Gastroenterology Associates ( Site 0253), New York
A’ fastadhÌre 3
Gach aois · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06651281

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

  • New York Gastroenterology Associates - Upper East Side /ID# 281767, New York
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

  • Westchester Putnam Gastroenterology PC, Carmel
  • Five Towns Gastroenterology, Cedarhurst
  • IMIDeology, Elmhurst
  • agus 5 a bharrachd
A’ fastadhÌre 4
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06581328

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • Ellipsis Research Group, Brooklyn
  • Smart Medical Research - Jackson Heights, Jackson Heights
  • Pioneer Clinical Research NY, New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  • Xencor Investigative Site, Albany
  • Xencor Investigative Site, Rochester
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  • Site 037, New York
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

  • Site US-002, Albany
  • Site US-016, Rochester
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07845487

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

  • Intercity Gastroenterology, Fresh Meadows
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06979336

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

  • Westchester Putnam Gastroenterology, Carmel
  • Inflammatory Bowel Disease Center at NYU Langone, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • agus 3 a bharrachd
A’ fastadhÌre 3
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07196748

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

  • Columbia University Medical Center, New York
A’ fastadhÌre 2/3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

  • Icahn School of Medicine at Mount Sinai, New York
  • New York Gastroenterology Associates, New York
  • Care Access - Yonkers, Yonkers
A’ fastadhÌre 3
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

  • NYU Langone Hospital - Long Island, Mineola
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

  • Digestive Disease Medicine of Central New York, Utica
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

  • Icahn School of Medicine at Mount Sinai, New York
A’ fastadhÌre 3
Aoisean 2 gu 19 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

  • Stony Brook University, Stony Brook
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

  • NYU Langone Health, New York
  • Weill Cornell Medical College- New York Presbyterian Hospital, New York
A’ fastadhÌre 4
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 21 Sult 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • MedTraits NY - Site Number: 8400045, Maspeth
  • Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040, New York
  • New York Gastroenterology Associates - Site Number: 8400009, New York
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT07185009

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

  • New York Gastroenterology Associates, New York
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Lùna 2026 · NCT07577856

A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

  • Fink Children's Ambulatory Care Center, New York
  • Kimmel Pavilion - NYU Langone, New York
  • NYU Grossman School of Medicine, New York
  • agus 4 a bharrachd
A’ fastadhÌre 2
Aoisean 2 gu 11 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07470879

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

  • Columbia University Medical Center, New York
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 21 Lùna 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  • MedTraits NY - Site Number: 8400045, Maspeth
  • Manhattan Clinical Research, LLC - Site Number: 8400069, New York
  • NYU Langone Health - Site Number: 8400091, New York
  • agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 16 gu 80 · Gach gnè · Air ùrachadh 20 Lùna 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

  • Saratoga Schenectady Gastroenterology Associates, Burnt Hills
  • NYU Langone Health, New York
  • Cornell University, New York
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 7 Lùna 2026 · NCT05230173

BOOM-IBD2 Pivotal Clinical Trial

  • Northwell Health North Shore University Hospital, Manhasset
  • Columbia University Irving Medical Center/New York Presbyterian Hospital, New York
A’ fastadh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06571669

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

  • New York University, New York
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

  • NYU Langone Health, New York
  • Lenox Hill Hospital, Northwell Health, New York
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 64 · Gach gnè · Air ùrachadh 9 Iuch 2026 · NCT06398626

A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)

  • New York Presbyterian Hospital, New York
A’ fastadhÌre 3
Aoisean 2 gu 17 · Gach gnè · Air ùrachadh 22 Ògmh 2026 · NCT06405087

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

  • Mirador Therapeutics Selected Site, New York
  • Mirador Therapeutics Selected Site, Rochester
A’ fastadhÌre 2
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 12 Màrt 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

  • State University of New York Upstate Medical University, Syracuse
A’ fastadh
Aoisean 18 gu 85 · Gach gnè · Air ùrachadh 8 Faoi 2026 · NCT05987852

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

  • New York University, New York
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Cèit 2025 · NCT06750731

Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.